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Epidermal growth factor receptor, isolated in the presence of the non-ionic detergent octylglucoside, was 
reconstituted into liposomes by detergent dialysis. The receptor was shown to be incorporated in the lipid 
bilayer with the EGF binding domain oriented to the outside of the liposomes and to retain its ability to 
bind EGF and an anti-receptor antibody in a specific manner. 
Epidermal growth factor receptor Reconstitution Liposome Octylglucoside 
1. INTRODUCTION 
The EGF receptor is a 170-kDa membrane- 
spanning glycoprotein which is able to bind EGF 
with high affinity and specificity. Upon binding, a 
variety of responses occur including clustering and 
internalization of EGF-receptor complexes, 
changes in ion fluxes, phosphorylation of cellular 
proteins and of the receptor itself at tyrosine 
residues and finally, upon prolonged stimulation 
(6-8 h), DNA synthesis occurs and the cells divide 
[l-3]. The amino acid sequence of the receptor has 
been deduced and the transmembrane and cyto- 
plasmic domains found to be closely related to the 
v-e&B oncogene product of avian erythro- 
blastosis virus [4]. The EGF binding activity is 
located in the extracellular portion of the molecule 
whereas the protein kinase activity is in the intra- 
cellular domain. 
Purification of the EGF receptor demands ex- 
traction of the molecule from the membrane bi- 
layer with detergents and so far studies on the 
isolated receptor have been conducted under these 
non-physiological conditions. We report here the 
reconstitution of purified receptor into artificial 
phospholipid bilayers using a detergent-dialysis 
method. We provide evidence for a uniform orien- 
tation of the receptor within the bilayer with the 
EGF binding domain facing outside the liposomes 
and show that the incorporated receptor is func- 
tional in binding EGF and a monoclonal anti- 
receptor antibody. This reconstitution system 
should prove useful for the study of the structure 
and function of the EGF receptor in a more 
physiological environment. 
2. MATERIALS AND METHODS 
Octylglucoside, phosphatidylcholine (PC), 
phosphatidylethanolamine (PE), cholesterol, pro- 
tease (from S. griseus), bovine serum albumin, 
phenylmethylsulfonyl fluoride (PMSF), rhod- 
amine isothiocyanate (RITC) and protein A- 
Sepharose were from Sigma. [3’S]Methionine 
(1400 Ci/mmol) and NalZ51 (15.1 mCi/mg) were 
from Amersham. All other chemicals were from 
BDH. 
Epidermal growth factor (EGF) was prepared 
from mouse submaxillary glands as described [5]. 
EGF receptor was purified from A43 1 cells (grown 
in DMEM/lO% foetal calf serum) as described [6], 
with the exception that octylglucoside (50 mM) 
was used instead of Triton X-100 or deoxycholate 
during elution of the protein from the EGF- 
affinity column. Radiolabelled receptor was 
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prepared in the same way from A431 cells in- 
cubated for 18 h with 30&i/ml [35S]methionine. 
The mouse monoclonal anti-EGF receptor anti- 
body (EGFRl) was a kind gift of Dr M.D. Water- 
field (ICRF, London). Both EGF and EGFRl were 
radiolabelled with “‘1 as described in [7]. 
SDS-polyacrylamide gel electrophoresis was per- 
formed as described [S]. Visualization of 35S- 
labelled proteins after impregnation of gels in 1 M 
sodium salicylate was by fluorography on pre- 
flashed Kodak XAR 5 film at -70°C [9]. 
Reconstitution: A mixture of PC, PE and 
cholesterol (2 : 1: 1, w/w) in 95% chloroform-5~0 
methanol was dried on the walls of a poly- 
propylene tube, redissolved in ether and redried 
twice under nitrogen with vortex-mixing to pro- 
duce a thin film. The lipid film was then dried 
under vacuum in a Speed-Vat concentrator for 2 h 
to remove traces of solvents. The mixture was 
dissolved in Tris-buffered saline (TBS: 20 mM 
Tris, 150 mM NaCl, pH 7.4) containing 50 mM 
octylglucoside. EGF receptor in 20 mM Tris, 
50 mM octylglucoside, 5 mM ethanolamine, 10% 
glycerol, 50 mM benzamidine, pH 8.0, was added 
and mixed by vigorous shaking or sonication for 
10 min. The final detergent-to-lipid ratio was 40 : 1 
(w/w) and the final protein-to-lipid ratio 1: 100 
(w/w). The solution was dialysed for 36 h against 
3 changes of TBS containing 30 mM benzamidine 
and 0.1 mM PMSF. The resulting turbid suspen- 
sion was either centrifuged at 100000 x g for 1 h 
to collect the liposomes or mixed with sucrose to 
40% and applied at the bottom of a gradient con- 
sisting of 0.5 ml 40% (w/v) sucrose, 1.5 ml 20% 
(w/v) sucrose and I.5 ml 5% (w/v) sucrose, 
followed by centrifugation at 400~ x g for 3 h in 
an SW55 rotor. Fractions were collected from the 
top of the gradient. For liposomes prepared with 
RITC-PE, the fluorescence of the fractions was 
measured in a Perkin-Elmer fluorimeter. 
Binding assays for [‘251]EGF and [‘251]EGFR1: 
Liposomes prepared using 1 pg receptor protein 
were pelleted by centrifugation and resuspended in 
50 ~1 TBS/O.l% BSA. [‘251]EGF (1.0&i, 27 ng) 
or [12?]EGFR1 (0.7 &i, 0.1 ,ug) were added and 
incubated for 1 h at room temperature. In control 
experiments, the liposomes were preincubated with 
a lOO-fold excess of unlabelled EGF or EGFRl for 
30 min. The liposomes were floated up sucrose 
gradients as above. Fractions were collected from 
the top and their radioactivity measured in a y- 
counter. 
Treatment with proteases: Protease inhibitors 
were omitted from the last change of dialysis buf- 
fer and liposomes were incubated with 5 pg/ml 
protease in TBS for 1 h at room temperature. Pro- 
tease inhibitors (30 mM benzamidine, 0.1 mM 
PMSF, 5 mM EDTA) were then added and after 
30 min the liposomes were washed 3 times in TBS 
by centrifuging for 10 min at 100000 x g in a 
Beckman Airfuge. 
Immunoprecipitation of EGF receptor: 
Liposomes were lysed in 50 mM Tris, 150 mM 
NaCl, 5 mM EDTA, 1% NP40, pH 8.0, for 
30 min at room temperature. 3 pug/ml of antibody 
EGFRl were added and incubated for 1 h at room 
temperature. Immune complexes were precipitated 
using protein A-Sepharose and [i2?]EGF binding 
assays were done directly on the beads as described 
above for liposomes, The beads were washed 6 
times in 50 mM Tris, 400 mM NaCl, 5 mM 
EDTA, 1% NP40, pH 8.0, and radioactivity 
measured in a y-counter. 
3. RESULTS AND DISCUSSION 
3.1. Reconstitution of the, EGF receptor 
Gctylglucoside was used for the isolation and 
reconstitution of the EGF receptor in liposomes 
because this detergent, having a high critical 
micelle concentration (25 mM), is rapidly and effi- 
ciently removed from protein and phospholipids 
by dialysis. The same method has been used suc- 
cessfully for the reconstitution of several other 
membrane proteins [lo-141. Mixing of purified 
receptor with phospholipids followed by removal 
of the detergent resulted in the formation of 
liposomes which were either pelleted by centrifuga- 
tion at 100000 x g for 1 h or were collected and 
separated from unincorporated materials by 
floating up a sucrose step gradient. To determine 
the position of the liposomes on the gradient a 
fluorescent derivative of PE was used in the 
reconstitution mixture. Free RITC-PE floated to 
the top of the gradient but a proportion of the 
fluorescent phospholipid banded at the 5-20% 
sucrose interface (fig.1). The association of EGF 
receptor with liposomes at this interface was deter- 
mined by using biosynthetically labelled receptor, 
purified from cells incubated with [35S]methionine, 
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Fig. 1. Density-gradient centrifugation of liposomes. 
Liposomes were prepared either with RITC-phos- 
phatidylethanolamine (A) or with [35S]methionine 
labelled EGF receptor (0.05 ,&i) (0) as described in sec- 
tion 2. The fluorograph shows SDS-PAGE in 9% gel of 
fractions 7-10. 
and analysing fractions by scintillation counting 
and SDS-PAGE followed by fluorography (fig. 1). 
Approx. 30% of the total amount of receptor was 
associated with the liposomes. 
When material from the 5-20070 interface was 
examined by electron microscopy using negative 
stain, typical vesicular structures were seen. 
3.2. Binding of labelled ligands Table 1 
The ability of the reconstituted receptor to bind 
specific ligands was tested using [‘*‘I]EGF and 
[ ‘*‘I]EGFR 1, a monoclonal anti-EGF receptor an- 
tibody [15]. Unbound ligands were removed by 
density gradient centrifugation. The reconstituted 
receptor was able to bind both [1251]EGF and 
[‘251]Rl. Binding of both ligands was specific, 
because it was prevented when the liposomes were 
preincubated with an excess of unlabelled ligand 
(fig.2, data shown only for EGF). No binding was 
observed, under the same conditions, to liposomes 
prepared without EGF receptor. 
Effects of protease treatment on liposomes 
(1) [35S]EGF receptor liposomes 
cpm at 5-20% interface 
- Protease 9320 
+ Protease 5270 
(2) [12’I]EGF binding on immunoprecipitated receptor 
cpm on protein A-Sepharose beads 
- Protease 5391 f 140 
+ Protease 638 f 28 
- EGF receptor 347 f 50 
3.3. Effects of protease treatment 
EGF receptor could have been associated with 
the liposomes in 3 ways: inserted in the bilayer, 
trapped inside, or adsorbed to the external lipid 
leaflet. To distinguish between these possibilities, 
experiments using proteolytic digestion were per- 
formed. It was first shown that when liposomes 
were exposed to protease under isotonic, 
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Fig.2. Binding of [‘2Sl]EGF to reconstituted EGF recep- 
tors. Binding assays were done as described in section 2 
on intact liposomes (0), liposomes pre-incubated with 
an excess of unlabelled EGF (A) and protease-treated 
liposomes (0). 
detergent-free conditions before testing for 
[‘*‘I]EGF binding, more than 95% of the specific 
binding was lost (fig.2). However, when liposomes 
incorporating [35S]methionine labelled EGF recep- 
tor were treated with proteases, about half of the 
radioactivity was lost (table I), suggesting that a 
(1) Radioactivity associated with the liposomes before 
and after protease treatment: Liposomes were prepared 
with 0.03 &i [%]EGF receptor and half were treated 
with proteases as described in section 2. (2) Liposomes, 
either untreated or protease treated were lysed and EGF 
receptors immunoprecipitated. [“‘IJEGF binding was 
tested on the protein A-Sepharose beads. To estimate 
background binding, liposomes were prepared without 
EGF receptor and tested in the same way 
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part of the EGF receptor molecule, lacking the 
EGF-binding site, remained associated with the 
liposomes and was protected from proteolytic 
degradation. When protease-treated [35S]EGF 
receptor bearing liposomes were analysed by SDS- 
PAGE, a single 92-kDa band appeared, whereas 
protease treatment in the presence of detergent 
resulted in much smaller fragments of the receptor 
(fig.3). Similar small fragments would have been 
produced if the receptor was adsorbed to the out- 
side but did not span the lipid bilayer, whereas a 
band corresponding to intact receptor would have 
been seen if receptor was trapped inside the 
liposomes and protected from proteases. 
Loss of EGF binding after protease treatment of 
intact liposomes does not necessarily mean that 
most of the reconstituted receptor molecules are 
‘correctly’ inserted in the bilayer, i.e., with the 
EGF binding domain facing the medium, as in the 
cell membrane. To test whether insertion was ran- 
dom, liposomes, either intact or protease treated, 
were lysed with detergent and the EGF receptors 
immunoprecipitated with the monoclonal antibody 
EGFRl and protein A-Sepharose. An [“‘IJEGF 
?+VX10-3 
4200 
492.5 
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Fig.3. Effect of protease treatment on the reconstituted 
EGF receptor. Fluorograph of SDS-PAGE (515% gra- 
dient gel) of intact [?j]EGF receptor liposomes (l), 
liposomes treated with proteases (2) and liposomes lysed 
in detergent and treated with proteases (3) 
binding assay was then done directly on the beads. 
It was found that protease treatment resulted in the 
loss of about 95% of [1251]EGF binding sites 
(table 1). This result demonstrates that the majori- 
ty of the EGF-binding sites are oriented to the out- 
side of the liposomes and only a small proportion 
(< 5%) within the liposomes. 
We believe that this reconstitution system will be 
important in the study of the EGF receptor 
molecule and its interactions with other cellular 
components. For this purpose we are developing a 
method for the efficient transfer of the 
reconstituted EGF receptors to receptor-negative 
cells. 
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